PAR · ATEME.PA
Ateme S.A.
€12.05+€0.55 (+4.78%)
Ateme S.A.’s quoted price sits in the upper half of its reported 52-week range, 14.54% below the high.
Loading market information…
PAR · EKI.PA · EUR
Stock price, earnings
Quote as of Oct 29, 2026, 04:35 PM UTC. Cached market data; not a live quote.
One-year closing-price history · EUR. Historical prices are not a forecast.
Ekinops S.a.’s quoted price sits in the lower half of its reported 52-week range, 43.29% below the high.
52-week range
Go beyond this overview with deeper company research in PortfolioX. Explore more in the app
BEHIND THE RESULTS
Ekinops S.a.’s next earnings report is currently expected on Mar 18, 2027. The reporting date and estimates may change.
Upcoming dates and analyst estimates may change. Fiscal quarters follow Ekinops S.a.’s reporting calendar.
THE COMPANY BEHIND THE TICKER
Ekinops S.A. specializes in delivering advanced telecommunications technology to both telecom operators and corporate clients, with operations spanning France and the international market. Its diverse product lineup includes Ekinops360, a sophisticated platform for optical transport and OTN switching. The company also offers OneAccess, comprising physical and virtualized access platforms specifically tailored for enterprise and edge network environments. Furthermore, Ekinops provides Compose, a comprehensive suite of software management tools and services designed to empower service providers in transitioning to software-defined networks, encompassing solutions for optical transmission, voice and data connectivity, and SDN enablement. Established in 2003, Ekinops maintains its headquarters in Lannion, France.
Latest available per-share figures in EUR. The payout ratio compares dividends with earnings.
About this data · PortfolioX market data, also available in the mobile app. Prices are displayed in the listing currency; dividend amounts use the currency shown in that section. Data availability and update times vary.
Page generated Oct 30, 2026, 04:54 AM UTC. Quotes retain their own timestamp above. Missing values appear as a dash. This page is for information only, not personalized investment advice.
| Q2 2023 | Oct 9, 2023 | €0.26-56.67% vs estimate | €71.00M0.0% vs estimate |
|---|
HOW THE BUSINESS IS PERFORMING
Statement amounts use the company’s reporting currency and are not converted to the stock’s listing currency. K = thousand, M = million, B = billion, T = trillion. Cash-flow figures are matched by fiscal year; missing figures appear as a dash.
PUT THE NUMBERS IN CONTEXT
Current metrics alongside available historical medians. A lower multiple or higher margin alone does not establish whether a stock is a good investment.
KEEP COMPARING
€12.05+€0.55 (+4.78%)
Ateme S.A.’s quoted price sits in the upper half of its reported 52-week range, 14.54% below the high.
€16.50+€0.75 (+4.76%)
LACROIX Group S.A.’s quoted price sits in the upper half of its reported 52-week range, 21.05% below the high.
€9.70+€0.20 (+2.11%)
Icape Holding S.A.’s quoted price sits in the upper half of its reported 52-week range, 2.41% below the high.
€0.94-€0.02 (-2.5%)
Netgem S.A.’s quoted price sits in the upper half of its reported 52-week range, 14.91% below the high.
€1.80+€0.05 (+2.86%)
Broadpeak S.A.’s quoted price sits in the lower half of its reported 52-week range, 35.71% below the high.
€12.45-€0.05 (-0.4%)
IT Link S.A.’s quoted price sits in the lower half of its reported 52-week range, 47.02% below the high.
€0.21-€0.01 (-2.72%)
Drone Volt S.A.’s quoted price sits in the lower half of its reported 52-week range, 73.77% below the high.
€0.15€0.00 (0.0%)
Octopus Biosafety S.A.’s quoted price sits in the lower half of its reported 52-week range, 60.53% below the high.
